Abstract:Purpose: The Adverse Outcome Pathway (AOP) framework, a systematic tool that can link available mechanistic data with phenotypic outcomes of relevance to regulatory decision-making, is being explored in areas related to radiation risk assessment. To examine the challenges including the use of AOPs to support the radiation protection community, an international horizon-style exercise was initiated through the Organisation for Economic Co-operation and Development Nuclear Energy Agency High-Level Group on Low Dose Research Radiation/Chemical AOP Joint Topical Group. The objective of the HSE was to facilitate the collection of ideas from a range of experts, to short-list a set of priority research questions that could, if answered, improve the description of the radiation dose-response relationship for low dose/dose-rate exposures, as well as reduce uncertainties in estimating the risk of developing adverse health outcomes following such exposures. Materials and methods: The HSE was guided by an international steering committee of radiation risk experts. In the first phase, research questions were solicited on areas that can be supported by the AOP framework, or challenges on the use of AOPs in radiation risk assessment. In the second phase, questions received were refined and sorted by the SC using a best-worst scaling method. During a virtual 3-day workshop, the list of questions was further narrowed. In the third phase, an international survey of the broader radiation protection community led to an orderly ranking of the top questions. Results: Of the 271 questions solicited, 254 were accepted and categorized into 9 themes. These were further refined to the top 25 prioritized questions. Among these, the higher ranked questions will be considered as 'important' to drive future initiatives in the low dose radiation protection community. These included questions on the ability of AOPs to delineate responses across different levels of biological organization, and how AOPs could be applied to address research questions on radiation quality, doses or dose-rates, exposure time patterns and deliveries, and uncertainties in low dose/dose-rate effects. A better understanding of these concepts is required to support the use of the AOP framework in radiation risk assessment. Conclusion: Through dissemination of these results and considerations on next steps, the JTG will address select priority questions to advance the development and use of AOPs in the radiation protection community. The major themes observed will be discussed in the context of their relevance to areas of research that support the system of radiation protection.

The First Steps on AOPs' Concepts, Development, and Applications in Teratology

Adverse outcome pathways: opportunities, limitations and open questions

The adverse outcome pathway concept: a pragmatic tool in toxicology

Harvesting the promise of AOPs: An assessment and recommendations

Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment

Adverse Outcome Pathways Guide and toxicity test applications

AOP Report: An Upstream Network for Reduced Androgen Signaling Leading to Altered Gene Expression of Androgen Receptor–Responsive Genes in Target Tissues

Crowdsourcing AOP development: Leveraging the thesis literature review to identify knowledge gaps and facilitate research translation

Adverse Outcome Pathways Mechanistically Describing Hepatotoxicity

Proof of concept for quantitative adverse outcome pathway modeling of chronic toxicity in repeated exposure

A toxicity pathway-oriented approach to develop adverse outcome pathway: AHR activation as a case study

Adverse Outcome Pathway Networks II: Network Analytics.

Mapping Adverse Outcome Pathways for Kidney Injury as a Basis for the Development of Mechanism-Based Animal-Sparing Approaches to Assessment of Nephrotoxicity

Application of Adverse Outcome Pathways Framework in Monitoring of Toxic Chemicals from Aquatic Environments

Development of an adverse outcome pathway network for nephrotoxicity

Potential adverse outcome pathways with hazard identification of organophosphate esters

Adverse Outcome Pathway Network Approach to Identify Endocrine Disruptor-Induced Reproductive Toxicity

Radiation adverse outcome pathways (AOPs) are on the horizon: advancing radiation protection through an international Horizon-Style exercise

Causal, Predictive or Observational? Different Understandings of Key Event Relationships for Adverse Outcome Pathways and Their Implications on Practice

The potential connections of adverse outcome pathways with the hazard identifications of typical organophosphate esters based on toxicity mechanisms

Developing adverse outcome pathways on silver nanoparticle-induced reproductive toxicity via oxidative stress in the nematode Caenorhabditis elegans using a Bayesian network model